This Pharma Magazine is the source for a plethora of unique Pharma articles. Several notable figures from top pharma organisations are featured in the R&D, Manufacturing and Clinical Trials sections, with their expert knowledge of the field.
The COVID pandemic has impacted many industries alike and the impact on biosimilars market was no different Lockdowns causing short fall of resources delays in clinical trials slowdown in FDA approvals of nonCOVID drugs have influenced the RD activities and the biosimilars pipeline
Pharmaceutical companies of all sizes are increasingly outsourcing elements of the development process including regulatory affairs This helps them to access specific technical regulatory or geographic expertise to flexibly augment staffing levels without adding to headcount and to deliver key operational outputs enabling internal staff to focus on...
The first Biosimilar was approved in the year in the European Union and since then there have been more than biosimilar drugs that have been approved Not surprisingly there has been phenomenal growth in the biosimilars market an Assocham report states that the global biosimilars market is estimated to reach US billion by while the Indian biosimi...
Latest figures show that China is the second pharmaceutical market in the world after the United States with an overall value amounting to about billion dollars in
Every life science company is eager to find and absorb industry best practices and for good reason In a business environment that is changing quickly no firm can afford to be left behind and relying on internal experience and lessons is too slow It is essential to imitate as well as to innovate
Vaccines derived from live attenuated viruses are required by law to be subject to tests for residual neurovirulence before use This applies to vaccines which comprise whole neurotropic viruses vaccines which have a neurotropic component or those which have been passaged in neural tissue
Proactive quality risk management provides numerous advantages to pharmaceutical companies such as less rejected batches and less drug shortages FDA a It helps to minimise and predict potential negative impact on patients caused by quality issues and it encourages manufacturers to adopt suitable continuous improvement programs
Monoclonal antibodies mAbs are the highest selling class of biologics due to their specific action and reduced immunogenicity As the use of mAbs promotes treating many diseases eg cancer with better targeted immunological approaches the development of mAbs will continue to increase
Solubility is an important physicochemical factor affecting absorption of drug and its therapeutic effectiveness The poor aqueous solubility of drugs is still now a challenge in formulation and development Due to the poor aqueous solubility the dissolution as well as bioavailability decrease which may be insufficient
Polysaccharide derivatives are extensively used in chiral stationary phases They provide multiple advantages including broad enantioselectivity better resolution ability easy availability and high loadability under preparative separation conditions Commercially available chiral stationary phases CSPs of this type are usually coated onto a silica ma...
Over the years there have been many expensive and notorious incidents that have prompted the necessity of cyberphysical security of manufacturing plants Stuxnet Duqu Flame and Gauss were malware specifically designed to target industrial control systems ICS and cause physical damage to the equipment and inhibit processes from executing normally
One of the biggest challenges confronting pharma and biotech companies globally is the everincreasing RD costs to bring new drugs into the market The regulatory approvals are also getting more stringent which stretches the overall time required for new launches
ClinPro Research established in Feb is an ISO certified fullservice capability CRO headquartered in Mumbai India We cater to the clinical requirements of both domestic and international pharmaceutical companies biotech companies medical device companies ayurvedic and nutraceutical companies with our exceptional suite of solutions which includes e...
In the highly competitive pharma market quality has become the key differentiator for almost all products and services Quality control is essential for building a successful business that delivers products that meet or exceed customers expectations